IMRT 2018

Final remarks on IMRT for Hodgkin Lymhoma

• IMRT is a powerful tool to deliver RT on lymphoma volumes, achieving a high degree of heart sparing • Secondary malignancies following lower doses may be controlled by using specific constraints and models do not predict a higher incidence • IMRT means many different technical solutions • Protons are attractive but more data are needed and some challenges remain on breath control and margins, with potential disadvantages